Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

  • The following term was not found in PubMed: s%C3%B8rensen.
1.

Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents.

Zhang X, Liu Q, Li Q, Li Y, Liu Z, Deng H, Tang S, Wang Y, Wang Y, Song D.

Acta Pharm Sin B. 2018 Jul;8(4):629-638. doi: 10.1016/j.apsb.2018.01.006. Epub 2018 Feb 21.

2.

Immunodeficiency.

Justiz Vaillant AA, Qurie A.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

3.

Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis.

Shen L, Zheng J, Wang Y, Zhu M, Zhu H, Cheng Q, Li Q.

BMC Infect Dis. 2017 Jan 4;17(1):7. doi: 10.1186/s12879-016-2107-9.

4.

Transcriptomics analysis and hormonal changes of male and female neonatal rats treated chronically with a low dose of acrylamide in their drinking water.

Collí-Dulá RC, Friedman MA, Hansen B, Denslow ND.

Toxicol Rep. 2016 Mar 19;3:414-426. doi: 10.1016/j.toxrep.2016.03.009. eCollection 2016.

5.

Diversity of HIV/AIDS epidemic in China: a result from hierarchical clustering analysis and spatial autocorrelation analysis.

Qian S, Guo W, Xing J, Qin Q, Ding Z, Chen F, Peng Z, Wang L.

AIDS. 2014 Jul 31;28(12):1805-13. doi: 10.1097/QAD.0000000000000323.

PMID:
24906111
6.

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.

Gottardo R, Bailer RT, Korber BT, Gnanakaran S, Phillips J, Shen X, Tomaras GD, Turk E, Imholte G, Eckler L, Wenschuh H, Zerweck J, Greene K, Gao H, Berman PW, Francis D, Sinangil F, Lee C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, Robb ML, Michael NL, Kim JH, Zolla-Pazner S, Haynes BF, Mascola JR, Self S, Gilbert P, Montefiori DC.

PLoS One. 2013 Sep 26;8(9):e75665. doi: 10.1371/journal.pone.0075665. eCollection 2013.

7.

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design.

Chen Y, Vaine M, Wallace A, Han D, Wan S, Seaman MS, Montefiori D, Wang S, Lu S.

J Virol. 2013 Sep;87(18):10232-43. doi: 10.1128/JVI.00837-13. Epub 2013 Jul 17.

8.

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate.

Visciano ML, Tagliamonte M, Stewart-Jones G, Heyndrickx L, Vanham G, Jansson M, Fomsgaard A, Grevstad B, Ramaswamy M, Buonaguro FM, Tornesello ML, Biswas P, Scarlatti G, Buonaguro L; NGIN Consortium.

J Transl Med. 2013 Jul 8;11:165. doi: 10.1186/1479-5876-11-165.

9.

Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?

Minassi A, Sánchez-Duffhues G, Collado JA, Muñoz E, Appendino G.

J Nat Prod. 2013 Jun 28;76(6):1105-12. doi: 10.1021/np400148e. Epub 2013 Jun 6.

PMID:
23742639
10.

A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam.

Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, Nguyen BT, Connell J, Coughlan S, Nguyen HT, Hall WW, Thi LA.

PLoS One. 2012;7(6):e39027. doi: 10.1371/journal.pone.0039027. Epub 2012 Jun 13.

11.

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum.

Friedman J, Alam SM, Shen X, Xia SM, Stewart S, Anasti K, Pollara J, Fouda GG, Yang G, Kelsoe G, Ferrari G, Tomaras GD, Haynes BF, Liao HX, Moody MA, Permar SR.

PLoS One. 2012;7(5):e37648. doi: 10.1371/journal.pone.0037648. Epub 2012 May 18.

12.

An additive effect of protective host genetic factors correlates with HIV nonprogression status.

Salgado M, Simón A, Sanz-Minguela B, Rallón NI, López M, Vicario JL, Benito JM, Rodés B.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):300-5. doi: 10.1097/QAI.0b013e3182036f14.

PMID:
21084992
13.

Formation of aminyl radicals on electron attachment to AZT: abstraction from the sugar phosphate backbone versus one-electron oxidation of guanine.

Adhikary A, Khanduri D, Pottiboyina V, Rice CT, Sevilla MD.

J Phys Chem B. 2010 Jul 22;114(28):9289-99. doi: 10.1021/jp103403p.

14.

Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.

Canducci F, Marinozzi MC, Sampaolo M, Berrè S, Bagnarelli P, Degano M, Gallotta G, Mazzi B, Lemey P, Burioni R, Clementi M.

Retrovirology. 2009 Jan 15;6:4. doi: 10.1186/1742-4690-6-4.

15.

Epidemiology of hepatitis B, C, and E viruses and human immunodeficiency virus infections in Tahuna, Sangihe-Talaud Archipelago, Indonesia.

Achwan WA, Muttaqin Z, Zakaria E, Depamede SA, Mulyanto, Sumoharjo S, Tsuda F, Takahashi K, Abe N, Mishiro S.

Intervirology. 2007;50(6):408-11. doi: 10.1159/000112915.

PMID:
18185013
16.

Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.

Morningstar ML, Roth T, Farnsworth DW, Smith MK, Watson K, Buckheit RW Jr, Das K, Zhang W, Arnold E, Julias JG, Hughes SH, Michejda CJ.

J Med Chem. 2007 Aug 23;50(17):4003-15. Epub 2007 Jul 31.

17.
18.

N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies.

Teeraputon S, Louisirirojchanakul S, Auewarakul P.

Viral Immunol. 2005;18(2):343-53.

PMID:
16035946
19.

Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Marozsan AJ, Moore DM, Lobritz MA, Fraundorf E, Abraha A, Reeves JD, Arts EJ.

J Virol. 2005 Jun;79(11):7121-34.

20.

Conserved neutralizing epitopes of HIV type 1 CRF01_AE against primary isolates in long-term nonprogressors.

Sreepian A, Srisurapanon S, Horthongkham N, Tunsupasawasdikul S, Kaoriangudom S, Khusmith S, Sutthent R.

AIDS Res Hum Retroviruses. 2004 May;20(5):531-42.

PMID:
15186528

Supplemental Content

Loading ...
Support Center